Search research articles
Contact Us
Filters
Showing results (471-480 of 565) with videos related to
Page
of 57
Sort By:
Journal of Translational Medicine
|
November 16, 2019
The OncoLifeS data-biobank for oncology: a comprehensive repository of clinical data, biological samples, and the patient's perspective
Grigory Sidorenkov, Janny Nagel, Coby Meijer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study
H J M Groen, A H W van der Leest, E Fokkema, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study
Lauren Averett Byers, Dmitry Bentsion, Steven Gans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2017
Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome
Jules L Derks, Noémie Leblay, Erik Thunnissen, et al.
The Lancet. Oncology
|
June 11, 2016
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial
Joan E Walter, Marjolein A Heuvelmans, Pim A de Jong, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 20, 2019
Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)
B C M Hermans, J L Derks, E Thunnissen, et al.
JCO Precision Oncology
|
January 20, 2022
Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non-Small-Cell Lung Cancer With Rare or Complex Mutational Profiles
Bart Koopman, Anthonie J van der Wekken, Arja Ter Elst, et al.
Thorax
|
April 9, 2011
CT-quantified emphysema in male heavy smokers: association with lung function decline
Firdaus A A Mohamed Hoesein, Bartjan de Hoop, Pieter Zanen, et al.
The Lancet. Oncology
|
April 16, 2013
Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study
Wieneke A Buikhuisen, Jacobus A Burgers, Andrew D Vincent, et al.
Epigenetics
|
July 6, 2016
RAB25 expression is epigenetically downregulated in oral and oropharyngeal squamous cell carcinoma with lymph node metastasis
M J A M Clausen, L J Melchers, M F Mastik, et al.
Page
of 57
Search research articles
Search
Showing results (471-480 of 565) with videos related to
Sort By:
Page
of 57
Journal of Translational Medicine
|
November 16, 2019
The OncoLifeS data-biobank for oncology: a comprehensive repository of clinical data, biological samples, and the patient's perspective
Grigory Sidorenkov, Janny Nagel, Coby Meijer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study
H J M Groen, A H W van der Leest, E Fokkema, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study
Lauren Averett Byers, Dmitry Bentsion, Steven Gans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2017
Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome
Jules L Derks, Noémie Leblay, Erik Thunnissen, et al.
The Lancet. Oncology
|
June 11, 2016
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial
Joan E Walter, Marjolein A Heuvelmans, Pim A de Jong, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 20, 2019
Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)
B C M Hermans, J L Derks, E Thunnissen, et al.
JCO Precision Oncology
|
January 20, 2022
Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non-Small-Cell Lung Cancer With Rare or Complex Mutational Profiles
Bart Koopman, Anthonie J van der Wekken, Arja Ter Elst, et al.
Thorax
|
April 9, 2011
CT-quantified emphysema in male heavy smokers: association with lung function decline
Firdaus A A Mohamed Hoesein, Bartjan de Hoop, Pieter Zanen, et al.
The Lancet. Oncology
|
April 16, 2013
Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study
Wieneke A Buikhuisen, Jacobus A Burgers, Andrew D Vincent, et al.
Epigenetics
|
July 6, 2016
RAB25 expression is epigenetically downregulated in oral and oropharyngeal squamous cell carcinoma with lymph node metastasis
M J A M Clausen, L J Melchers, M F Mastik, et al.
Page
of 57